Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Alvar

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Plos Neglected Tropical Diseases|June 20, 2024
A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and BangladeshShyam Sundar, Krishna Pandey, Dinesh Mondal, et al.
Clinical Drug Investigation|January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance ProgrammeRobert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Plos Neglected Tropical Diseases|November 21, 2023
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm studyBrima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, et al.
Plos Neglected Tropical Diseases|February 24, 2026
Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remainingRajib Chowdhury, Anupama Hazarika, Sabera Sultana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry TrialAhmed M Musa, Jane Mbui, Rezika Mohammed, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Plos Neglected Tropical Diseases|June 20, 2024
A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and BangladeshShyam Sundar, Krishna Pandey, Dinesh Mondal, et al.
Clinical Drug Investigation|January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance ProgrammeRobert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Plos Neglected Tropical Diseases|November 21, 2023
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm studyBrima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, et al.
Plos Neglected Tropical Diseases|February 24, 2026
Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remainingRajib Chowdhury, Anupama Hazarika, Sabera Sultana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry TrialAhmed M Musa, Jane Mbui, Rezika Mohammed, et al.
Pageof 10